-
Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
(PAR-20-212)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of Mental Health
Application Receipt Date(s): Only accepting applications for the AIDS Due Date(s) listed below.
-
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
(PAR-20-231)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
Application Receipt Date(s): Only accepting applications for the AIDS application receipt dates listed below.
-
Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed)
(PAR-20-232)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply
The first standard due date for this FOA is October 16, 2020
-
Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed)
(PAR-20-233)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply
The first standard due date for this FOA is October 5, 2020
-
NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)
(PAR-20-234)
National Institute on Aging
Application Receipt Date(s): July 1, 2020; August 3, 2020; September 1, 2020; October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2021; and February 1, 2021.
-
Behavioral Tasks Targeting Brain Systems Relevant to Anhedonia (R01 Basic Experimental Studies with Humans Required)
(PAR-20-235)
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply.
The first standard due date for this FOA is October 5, 2020
-
Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)
(PAR-20-237)
National Institute on Minority Health and Health Disparities
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Nursing Research
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
Office of Research on Women's Health
Office of Disease Prevention
National Center for Advancing Translational Sciences
Application Receipt Date(s): August 28, 2020; December 1, 2020
-
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
(RFA-AG-21-023)
National Institute on Aging
Application Receipt Date(s): November 13, 2020. No late applications will be accepted for this funding opportunity announcement.
-
Martin Delaney Collaboratories for HIV Cure Research (UM1 Clinical Trial Not Allowed)
(RFA-AI-20-035)
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
Martin Delaney Collaboratory for Pediatric HIV Cure Research (UM1 Clinical Trial Not Allowed)
(RFA-AI-20-036)
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional)
(RFA-DA-21-009)
National Institute on Drug Abuse
National Cancer Institute
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Application Receipt Date(s): October 19, 2020
No late applications will be accepted for this Funding Opportunity Announcement.
-
Laboratory, Data Analysis, and Coordinating Center (LDACC) for the Developmental Genotype-Tissue Expression Project(U24) (Clinical Trial Not Allowed)
(RFA-HG-20-039)
National Human Genome Research Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
Application Receipt Date(s): November 13, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01 - Clinical Trials Required)
(RFA-HL-21-001)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): December 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Regional Medical Libraries for the Network of the National Library of Medicine (UG4)
(RFA-LM-20-001)
National Library of Medicine
Application Receipt Date(s): September 11, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.